Global Soft Tissue Sarcoma Therapeutics Development Pipeline Review, H2 2015 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/wkfzrk/soft_tissue) has announced the addition of the "Soft Tissue Sarcoma - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Soft Tissue Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Soft Tissue Sarcoma and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Soft Tissue Sarcoma Overview
  3. Therapeutics Development
  4. Pipeline Products for Soft Tissue Sarcoma - Overview
  5. Pipeline Products for Soft Tissue Sarcoma - Comparative Analysis
  6. Soft Tissue Sarcoma - Therapeutics under Development by Companies
  7. Soft Tissue Sarcoma - Therapeutics under Investigation by Universities/Institutes
  8. Soft Tissue Sarcoma - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Soft Tissue Sarcoma - Products under Development by Companies
  13. Soft Tissue Sarcoma - Products under Investigation by Universities/Institutes
  14. Soft Tissue Sarcoma - Companies Involved in Therapeutics Development
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Amgen Inc.
  • Arog Pharmaceuticals, Inc.
  • Bayer AG
  • CASI Pharmaceuticals Inc.
  • Celgene Corporation
  • Cell Medica Limited
  • Cellceutix Corporation
  • Cellectar Biosciences, Inc.
  • CytRx Corporation
  • Daiichi Sankyo Company, Limited
  • Double Bond Pharmaceutical International AB
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • EpiZyme, Inc.
  • Exelixis, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gem Pharmaceuticals, LLC
  • GlaxoSmithKline Plc
  • Lytix Biopharma AS
  • MedImmune, LLC
  • Merck & Co., Inc.
  • Merrimack Pharmaceuticals, Inc.
  • Novartis AG
  • Noxxon Pharma AG
  • OncoTherapy Science, Inc.
  • Onxeo SA
  • Pfizer Inc.
  • Pharma Mar, S.A.
  • Philogen S.p.A.
  • Plexxikon Inc.
  • Siena Biotech S.p.A.
  • Sigma-Tau S.p.A.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Targovax AS

For more information visit http://www.researchandmarkets.com/research/wkfzrk/soft_tissue

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology